Sawgrass Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-2,116
| Closed | -$362K | – | 222 |
|
2018
Q3 | $362K | Sell |
2,116
-24
| -1% | -$4.11K | 0.02% | 180 |
|
2018
Q2 | $277K | Buy |
2,140
+136
| +7% | +$17.6K | 0.01% | 206 |
|
2018
Q1 | $206K | Sell |
2,004
-593
| -23% | -$61K | 0.01% | 205 |
|
2017
Q4 | $222K | Sell |
2,597
-304
| -10% | -$26K | 0.01% | 203 |
|
2017
Q3 | $246K | Buy |
+2,901
| New | +$246K | 0.01% | 198 |
|